SPONSORED | Listen to the Discovery_SA podcast on the importance of vaccines in the fight against Covid-19.
Dr Ronald Whelan, chief commercial officer at Discovery Health.Covid-19 vaccines are effective in protecting against infections and most specifically against severe Covid-19 disease and death. For those who have already been vaccinated, the vaccines have shown more than 80% protection against severe disease.
“These vaccines went through all the standard testing processes, and the clinical trials ran to scale and went through all the different gates required for approval,” says Dr Ronald Whelan, chief commercial officer at Discovery Health. In discussing some of the global vaccine trends, what the data says about the first, second and third waves, how to register to get vaccinated on the health scheme’s portal and more, Discovery Health’s podcast aims to help South Africans understand the importance of getting vaccinated.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
LISTEN | Cyril Ramaphosa's vaccine passport contradiction spotted by manyThe presidency seems to have had a change of heart regarding the potential implementation of a vaccine passport system.
Read more »
PODCAST | Vaccines and vaccine hesitationSPONSORED | Listen to episode 2 of the three-part podcast series by Discovery Health
Read more »
PODCAST | Vaccines and vaccine hesitationSPONSORED | ‘These vaccines went through all of the standard testing process, and the clinical trials ran to scale and went through all of the different gates required for approval.’ – Dr Ronald Whelan Discovery_SA chief commercial officer
Read more »
#VaxxFacts: What is in Covid-19 vaccines?UWC’s Associate Professor of Medical Biosciences Megan Shaw said the fact that none of the vaccines contains the Covid virus should assure people that the vaccines do not contain infectious material. VaxxFacts in partnership with UWConline
Read more »
French drugmaker Valneva plunges after UK scraps vaccine dealThe stock falls as much as 45% after the UK terminates a contract over allegations of a ‘breach of obligations’
Read more »
How to invest in the healthy future of vaccine stocksThere are some obstacles, such as patent waivers sought by SA and India, ahead, but the potential for long-term returns is huge
Read more »